GENZ Related Analyst Ratings

Nov 18, 2009 08:16 AM Morgan Joseph Reiterates a 'Buy' on Isis Pharmaceuticals (ISIS); Could Be Acquired by Potential Partners

Nov 18, 2009 07:30 AM Piper Jaffray Maintains an 'Overweight' on ISIS Pharmaceuticals (ISIS); Price Target Cut

Nov 13, 2009 02:23 PM Bank of America/ML Downgraded Genzyme (GENZ) to Underperform

Nov 13, 2009 02:16 PM Goldman Sachs Says FDA News on Genzyme (GENZ) is a "Significant Negative Surprise"

Nov 13, 2009 12:43 PM Deutsche Bank Says Genzyme (GENZ) FDA Warning May Not Be a Big Deal

Oct 13, 2009 07:50 AM Credit Suisse Initiates Coverage on Genzyme (GENZ) with a Neutral

Sep 24, 2009 09:20 AM FTN Equity Initiates Coverage on Genzyme (GENZ) with a Neutral

Sep 23, 2009 03:16 PM Wells Fargo Says Genzyme (GENZ) Guidance Eliminates Overhang; Maintains Outperform, But Lowers Estimates

Sep 21, 2009 07:28 AM Oppenheimer Downgrades Genzyme (GENZ) to Perform

Sep 18, 2009 07:19 AM Deutsche Bank Downgrades Genzyme (GENZ) to Hold; Risk/Reward Balanced

Sep 8, 2009 10:37 AM Piper Jaffray Downgrades Osiris Therapeutics (OSIR) to Neutral; Disappointing Top-Line Data From Phase III Trials

Sep 2, 2009 09:03 AM Hapoalim Securities Initiates Coverage on Protalix BioTherapeutics (PLX) with an Outperform; Attractive Entry Point

Aug 31, 2009 07:19 AM Baird Downgrades Genzyme (GENZ) to Neutral

Aug 31, 2009 06:53 AM Genzyme (GENZ): Colour on Allston problems

Aug 24, 2009 09:13 AM Collins Stewart Cuts Price Target on Genzyme (GENZ) to $63, But Reiterates Buy

Aug 21, 2009 08:26 AM Leerink Swann Upgrades Genzyme (GENZ) to Outperform; Odds Favor Outperformance

Aug 7, 2009 07:24 AM Goldman Sachs Added Genzyme (GENZ) to its Conviction Sell List

Aug 5, 2009 12:00 PM RBC Downgrades Genzyme (GENZ) to Sector Perform

Aug 3, 2009 08:11 AM UBS Downgrades Genzyme (GENZ) to Neutral

Jul 14, 2009 07:12 AM Leerink Swann Resumes Coverage on Genzyme (GENZ) with a Market Perform; Product & Pipeline Diversification Attractive

Jul 6, 2009 12:00 PM Protalix BioTherapeutics (PLX) Gets Huge Opportunity Due To Genzyme's (GENZ) Plant Shut-Down

Jun 26, 2009 08:19 AM Goldman Sachs Lowers Price Target On Genzyme (GENZ); Maintains Sell

Jun 23, 2009 10:24 AM RBC Capital Initiates Coverage on Genzyme (GENZ) with an Outperform

Jun 16, 2009 09:55 AM Baird Is a Buyer of BioMarin (BMRN) On Genzyme-Related Weakness

May 20, 2009 01:12 PM Barclays Gets Bullish On US Biotechnology Sector (BBH)

Apr 14, 2009 01:29 PM Collins Stewart Starts Genzyme (GENZ) at Buy

Apr 14, 2009 12:57 PM FTN Equity Starts Genzyme (GENZ) at Buy, Gilead (GILD), Amgen (AMGN) at Neutral

Mar 27, 2009 07:22 AM Piper Jaffray Initiates Coverage on Genzyme (GENZ) with a Buy; Attractive Entry Point

Mar 19, 2009 07:51 AM Baird Said a Genzyme (GENZ) Takeover Of BioMarin (BMRN) Makes Sense To Them

Mar 9, 2009 07:31 AM Deutsche Bank Upgrades Genzyme (GENZ) to Buy; Myozyme Delays Create Buying Opportunity

Mar 6, 2009 07:31 AM Goldman Sachs Downgrades Genzyme (GENZ) to Sell

Mar 3, 2009 08:33 AM Citi Downgrades Genzyme (GENZ) to Hold, Citing Lack of Visibility

Feb 19, 2009 08:46 AM Citi Downgrades BioMarin Pharmaceutical (BMRN) to Hold, Citing Disappointing Guidance

Feb 4, 2009 07:49 AM Goldman Sachs resumes coverage on Genzyme (GENZ) wiht a Buy

Jan 6, 2009 08:45 AM Morgan Joseph Initiates Coverage on Genzyme (GENZ) with a Buy

Sep 22, 2008 03:33 PM Deutsche Bank Comments on Genzyme (GENZ) Related to FX Exposure

Sep 8, 2008 07:32 AM Morgan Stanley Initiates Coverage on Genzyme (GENZ) with an Overweight

Sep 5, 2008 07:32 AM Merrill Lynch Resumes Coverage on Genzyme (GENZ) with a Buy

Aug 5, 2008 08:32 AM Banc of America Starts Genzyme (GENZ) at Buy

Jul 14, 2008 07:53 AM Citi Upgrades Genzyme (GENZ) to Buy

Jul 1, 2008 06:23 AM UBS Starts Genzyme (GENZ) at Buy

Jun 18, 2008 05:11 PM Deutsche Bank Starts Genzyme (GENZ) at Hold

Jun 18, 2008 04:25 PM Deutsche Bank Starts Coverage on Large Biotechs; DNA, GILD & AMGN Rated Buys, BIIB & GENZ Rated Holds

May 14, 2008 07:41 AM Sanford Bernstein Upgrades Genzyme (GENZ) to Outperform

Apr 4, 2008 08:50 AM Lazard Capital Starts Genzyme (GENZ) at Buy

Jan 15, 2008 08:44 AM Wachovia raises its valuation range on Genzyme (GENZ) to $90-$95

Jan 14, 2008 10:20 AM BWS Financial Says ISIS Pharma (ISIS) Could Goto $30

Jan 8, 2008 08:58 AM Analyst Firms Raise Price Targets on ISIS Pharmaceuticals (ISIS)

Dec 13, 2007 11:21 AM Baird Said Myozyme Study Success Removes Major Overhang for Genzyme (GENZ)

Nov 27, 2007 11:11 AM Bernstein Downgraded Biotech Sector to Neutral